Researchers in Singapore have designed an injectable, sustained drug-release gel shown to reduce scarring in patients that have undergone glaucoma surgery. This work focuses on sustained exposure to the anti-scarring drugs over two days...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)